Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/2004
08/26/2004US20040166488 Viral genome for use in generating polyclonal and monoclonal antibodies, hepatitis gene therapy models, and antiviral drug screening
08/26/2004US20040166121 Viricides from transgenic plant; dna sequences codes gene expression on surface of antigen ; insertion of nucleotide sequence into plant; genetic engineering
08/26/2004US20040166120 Polypeptides; free of adjuvants; antigen immunology response
08/26/2004US20040166109 Modulator polypeptide for regulation of intracellular endocytosis of amyloid precursor proteins; diagnosis and treatment of neurodegenerative disorders
08/26/2004US20040166026 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
08/25/2004EP1448782A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
08/25/2004EP0922092B1 Method of attenuating viruses
08/25/2004EP0839054B1 Tissue or cell-specific herpes simplex virus replication
08/25/2004EP0833903B1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
08/25/2004CN1524088A A virus causing respiratory tract illness in susceptible mammals
08/25/2004CN1523114A T4 bacteriophage surface exogenous protein high effective expression vector and establishing method thereof
08/25/2004CN1523103A Pseudorabies TK*/gE*/gI* gene dificiency mark live vaccine and preparation method thereof
08/25/2004CN1163604C Gene 62 of attenuated varicella virus strain and method for identifying virus strain for attenuated live vaccine using the gene
08/25/2004CN1163595C Process for inactivation of viruse with aid of acridine or acridine derivative
08/24/2004US6780630 Comprises live and inactivated vaccines; immunogens; for human and animal infants
08/24/2004US6780618 Performing a mutagenesis of the foreign gene to provide even distribution of g/c content throughout; genetic engineered polio virus
08/24/2004US6780612 Methods for the propagation of lytic organisms
08/24/2004US6780407 Recombinant attenuated avipox virus containing exogenous dna in nonessential region, that expresses exogenous dna encoding carcinoembryonic antigen and exogenous dna encoding b7 protein
08/19/2004WO2004069279A1 Composition for intracellular transport of biological particles or macromolecules
08/19/2004WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
08/19/2004WO2004050829A3 Recombinant double-stranded rna phage, and use of the same
08/19/2004WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
08/19/2004WO2003037260A3 Methods and compositions for treating parkinson's disease
08/19/2004US20040161847 Plasimd comprising regulatory sequence for cardiac specific expression of heterologous nucleotide sequences and proteins; tissue engineering; gene therapy and drug delivery
08/19/2004US20040161431 Antibacterial therapy with bacteriophage physico-chemically altered to delay inactiovation by the host defense system
08/19/2004US20040161411 Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense system
08/19/2004CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
08/18/2004EP1446490A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
08/18/2004EP1446488A2 Regulated nucleic acid expression system
08/18/2004EP1446479A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
08/18/2004EP0835137B1 Encapsulated cells producing viral particles
08/18/2004EP0817851B9 Dna encoding human papilloma virus type 18
08/18/2004EP0706387B1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
08/18/2004CN1162547C Hepatitis B virus antisense RNA expression vector targeting liver cancer and its construction process and use
08/18/2004CN1162447C Use of SR-15 protein molecules
08/18/2004CN1162182C Method of protein production using chondriosome translation system
08/17/2004US6777247 Nervous necrosis virus protein
08/17/2004US6777220 Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
08/17/2004US6777203 Telomerase promoter driving expression of therapeutic gene sequences
08/17/2004US6776988 Vectors for gene mutagenesis and gene discovery
08/17/2004US6776985 Encapsulated cells producing viral particles
08/17/2004CA2325228C Catalytic domain of the human effector cell cycle checkpoint protein kinase, chk1, materials and methods for identification of inhibitors thereof
08/12/2004WO2004066947A2 Hyperthermia oncolysis co-therapy
08/12/2004WO2004050680A3 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
08/12/2004WO2004016222A3 Hepatitis c viral-like particle purification
08/12/2004US20040157311 isolatable from turkeys in the field; makes these viruses particularly suited for preparing a live vaccine for protecting poultry against disease conditions resulting from infection
08/12/2004US20040157310 Methods for enhancing the production of viral vaccines in cell culture
08/12/2004US20040157239 Endonuclease capable of cleaving DNA from divalent cations, which retains its activity in acidic to neutral pH range, and is not inhibited by G-actin; treatment of cystic fibrosis
08/12/2004US20040157212 to suitable titer on Vero cells, without prior adaptation; shows reactivity in an immuno-fluorescence-technique (IFT) with a polyclonal antiserum raised against a reovirus; for vaccines
08/12/2004US20040156868 Chicken anaemia viruses of low pathogenicity
08/12/2004US20040156863 administering chimeric, carboxy-terminal truncated hepatitis B virus nucleocapsid (core) protein that is engineered for both enhanced stability of self-assembled particles and the substantial absence of nucleic acid binding by those particles
08/12/2004US20040156831 The modified holin inactivates the bacterial host prior to production of bacteriophage, so that the bacteriophage infection is non-productive; potential for generation of immune responses against the phage is reduced.
08/12/2004CA2512161A1 Hyperthermia oncolysis co-therapy
08/11/2004EP1445322A1 Packaging systems for human recombinant adenovirus to be used in gene therapy
08/11/2004EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
08/11/2004EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
08/11/2004CN1161469C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
08/11/2004CN1161460C Type-O hoof-and-mouth disease virus, type-O hoof-and-mouth disease vaccine with viurs and active component and prepn of the vaccine
08/11/2004CN1161459C Recombinant adenovirus expressig human rotavirus VP7 and its preparing process and usage
08/11/2004CN1161458C Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing same
08/10/2004US6774209 Synthetic, isolated polypeptides overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon; for imaging
08/10/2004US6774119 Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
08/10/2004US6773915 Detecting antibodies; culture product
08/10/2004US6773909 Concentration and lysis of adenovirus-infected cells in a single unit operation
08/10/2004US6773908 From open reading frames; vaccines
08/10/2004US6773710 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
08/10/2004US6773709 Chicken embryo lethal (CELO) virus
08/05/2004WO2004055216A3 Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells
08/05/2004WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof
08/05/2004US20040152635 For blocking the infectiousness of human immunodeficiency virus (HIV) in vivo or in vitro
08/05/2004US20040152183 Isolating infectious and non-infectious adenoviral or adenoassociated vector particles using chromatographic matrix; gene transfer tools and genetic engineering
08/05/2004US20040152182 Viral particles released after infection by human cytomegalovirus, and their use as vaccine
08/05/2004US20040152181 In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
08/05/2004US20040152069 Synthetic gagpol genes and their uses
08/05/2004US20040151620 Rapid sterilization and vaccine preparation
08/04/2004EP1442792A1 Photocatalytic material and utilization thereof
08/04/2004EP1441764A2 Antigen arrays comprising rankl for treatment of bone disease
08/04/2004EP1441761A2 Methods of preventing and treating flavivirus infection in animals
08/04/2004EP0953054B1 Ehv-1 vectors
08/04/2004CN1518457A Methods of inducing cytotoxic immune response and recombinant simian ademovirus compositions useful therein
08/04/2004CN1160454C Enhanced immunogen for inactivated vaccine for infection with Japanese ence phalitis viruses and process for producing the same
08/04/2004CN1160453C Systems and methods for removing viral agents from blood
08/03/2004US6770274 Viral mutant HSV mediated destruction of neoplastic cells
08/03/2004CA2362367C Telomerase reverse transcriptase transcriptional regulatory sequences
08/03/2004CA2144317C Hepatitis a virus vaccines
07/2004
07/29/2004WO2004063343A2 Dual expression vector system for antibody expression in bacterial and mammalian cells
07/29/2004WO2004062584A2 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
07/29/2004WO2004062567A2 Arterivirus marker vaccine
07/29/2004WO2004048402A3 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
07/29/2004WO2004045645A3 A bacteriophage preparation of enhanced stability by application of a block copolymer of ethylene oxide and propylene oxide
07/29/2004WO2003103578A3 Bacteriophage and enzymes lytic to salmonellae
07/29/2004WO2003083065A3 Improved methods for achieving expression from alphavirus vectors
07/29/2004WO2003076596A3 Altering viral tropism
07/29/2004WO2003072722A3 IMMUNOGENIC AVIAN HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
07/29/2004WO2003018623A3 Papillomavirus proteins and pharmaceutical compositions
07/29/2004WO2003011209A3 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes
07/29/2004US20040147467 For producing an immune response in fish
07/29/2004US20040146861 Diagnosing and treating cancer cells using mutant viruses
07/29/2004US20040146859 Nucleotide sequences coding hemorrhagic viral protein for use in detection and treatment of viral diseases; viricides; genetic vaccines
07/29/2004US20040146856 Viral vector coding antiproliferative agent for treatment of tumors; antitumor agents and artificial chromosome gene therapy